Precision Medicine News and Research

RSS

New research from Wake Forest Baptist looks at gene expression profiling in breast cancer

Predicting outcomes for cancer patients based on tumor-immune system interactions is an emerging clinical approach, and new research from Wake Forest Baptist Medical Center is advancing the field when it comes to the most deadly types of breast cancer.

10 May 2013

Precision Therapeutics to present clinical data of ChemoFx chemoresponse assay at WAGO meeting

Precision Therapeutics, Inc., a life science company that develops personalized medicine products for individualizing cancer care, today announced that a clinical study which demonstrates the feasibility of the ChemoFx chemoresponse assay to identify patients unlikely to respond to first-line therapy has been accepted for presentation at the 2013 Annual Meeting of the Western Association of Gynecologic Oncologists.

9 May 2013

NIH official raises concerns about new psychiatry manual

The director of the National Institute of Mental Health says the American Psychiatric Association's DSM-5 lacks validity, and his organization plans to launch a possible replacement diagnostic tool.

9 May 2013

Exosome Diagnostics' urine exosome technology accurately predicts outcome of prostate biopsy

Exosome Diagnostics, a leading developer of biofluid-based molecular diagnostic products for use in personalized medicine research and clinical diagnostics, today announced the presentation of data at the American Urological Association Annual Meeting in San Diego demonstrating the performance of urine exosome technology in accurately predicting the outcome of a prostate biopsy.

9 May 2013

Study shows patient selection based on biosamples makes clinical trials more efficient, reduces costs

Researchers at Moffitt Cancer Center say identifying and selecting participants for phase II cancer clinical trials from a centralized warehouse of patient-donated biological data expedites participant accrual, reduces trial size, saves money, and may speed test drugs through the drug development pipeline.

8 May 2013

Expert to explain how drugs induce damage to DNA in public lecture on May 16

Anticancer drugs save lives and/or improve the quality of life for many cancer patients. Many anti-cancer drugs work by killing tumor cells after inducing damage to DNA.

4 May 2013

Cancer Genetics introduces proprietary urogenital cancer array for diagnosing kidney cancer

Cancer Genetics, Inc., a leader in oncology-focused personalized medicine, has launched a proprietary urogenital cancer array, UroGenRA, intended for kidney cancer diagnosis and subtyping in its own laboratory.

3 May 2013

Hospital for Special Surgery receives grant for new genomics center to study autoimmune diseases

Hospital for Special Surgery in New York City has received a $5.6 million grant from The Tow Foundation to establish the Hospital for Special Surgery Genomics Center.

25 Apr 2013

Study suggests lung cancer patients with HER2 mutations may benefit from anti-HER2 drugs

New results from a retrospective study conducted in Europe suggest that anti-HER2 treatments, like the widely used breast cancer agent trastuzumab (Herceptin), have anti-cancer effects in a small subset of patients with advanced non-small cell lung cancer (NSCLC) harboring specific HER2 protein mutations.

23 Apr 2013

OHSU, Intel team up to develop technologies to make personalized genomic analysis faster

Oregon Health & Science University and Intel Corp. are teaming up to develop next-generation computing technologies that advance the field of personalized medicine by dramatically increasing the speed, precision and cost-effectiveness of analyzing a patient's individual genetic profile.

23 Apr 2013

Medical researchers race to find ways to use gene sequencing to fight cancer

Technology is quickly revamping medical care. The New York Times looks at the possible use of gene sequencing, while other news outlets examine apps and online tools that are helping Alzheimer's and autism caregivers.

23 Apr 2013

First Edition: April 22, 2013

Today's headlines include reports ranging from how state leaders are dealing with the consequences of rejecting the health law's Medicaid expansion to how pending immigration reform proposals could ease the nation's physician shortage.

22 Apr 2013

HUGO recognizes Dr. Patrick Tan for research on genomic profiles of Asian cancers

Dr Patrick Tan from A*STAR's Genome Institute of Singapore has received the 2013 Chen New Investigator Award from the international Human Genome Organisation.

19 Apr 2013

Albert Einstein College of Medicine joins New York Genome Center

Albert Einstein College of Medicine of Yeshiva University will join the New York Genome Center (NYGC) as its twelfth Institutional Founding Member.

17 Apr 2013

High court seems skeptical that biotech firm can patent human genes

Supreme Court justices seemed to express skepticism Monday that a biotech company can patent human genes isolated from the body that signal a greater likelihood of ovarian or breast cancer.

17 Apr 2013

UCLA researchers classify kidney cancer into several unique subtypes

Researchers with the Institute of Urologic Oncology and the Department of Urology at UCLA have classified kidney cancer into several unique subtypes, a finding that will help physicians tailor treatment to individual patients and that moves cancer care one step closer to personalized medicine.

17 Apr 2013

Precision Medicine News and Research

New research from Wake Forest Baptist looks at gene expression profiling in breast cancer

Precision Therapeutics to present clinical data of ChemoFx chemoresponse assay at WAGO meeting

NIH official raises concerns about new psychiatry manual

Exosome Diagnostics' urine exosome technology accurately predicts outcome of prostate biopsy

Study shows patient selection based on biosamples makes clinical trials more efficient, reduces costs

Expert to explain how drugs induce damage to DNA in public lecture on May 16

Cancer Genetics introduces proprietary urogenital cancer array for diagnosing kidney cancer

Hospital for Special Surgery receives grant for new genomics center to study autoimmune diseases

Study suggests lung cancer patients with HER2 mutations may benefit from anti-HER2 drugs

OHSU, Intel team up to develop technologies to make personalized genomic analysis faster

Medical researchers race to find ways to use gene sequencing to fight cancer

First Edition: April 22, 2013

HUGO recognizes Dr. Patrick Tan for research on genomic profiles of Asian cancers

Albert Einstein College of Medicine joins New York Genome Center

High court seems skeptical that biotech firm can patent human genes

UCLA researchers classify kidney cancer into several unique subtypes

Researchers discover 14 new genetic variations associated with heart rate

FDA lengthens review periods for IVD tests that utilize molecular biomarkers

Improvement in application of health information technology needed for better patient care

CvergenX to develop radiosensitivity test to better radiation therapy decisions for patients with cancer

Editorial Focus eBook - Peptides and Oligonucleotides (2nd edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News